Shares Outstanding: 92.169m
Cash: 134.5m
Current liabilities: 13.515m
Current ratio: 10.25
NWC (total current assets - total current liabilities): 125.123m
Monthly Burn rate (net cash used in operating activities / months): 4.24m
Estimated current cash: 126m
Accumulated deficit: 463m
Book value per share (Stock holder equity / Shares outstanding): 6.06
Baby Shelf Exemption price per share: 0.813
Jan 2018 F-10 (like S-3) for $250m ATM
$30m prospectus in November 2018, believed to be all used
$40m prospectus in September 2019, not sure if its all used
Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus Nephritis
Enough cash for 2.5 years of operation / They could have raised more from $25 to $15
$15 is deathline, held all day
-Gapped up to 25
-Bounced from 16 to 19 in YAH
-Faded all day but held 15 cleanly
-Making bearish wedge against 15
First Test Short of 17.15 level in PM
Had a scare when it topped at 17.45, plan was to stop out if 17.50 broke, took profits quickly and didn't hold 1/4 for a bigger move.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2019-12-05 08:23:58 | AUPH | sell | $17.050 | short |
2019-12-05 08:25:22 | AUPH | sell | $17.100 | short |
2019-12-05 08:25:23 | AUPH | sell | $17.150 | short |
2019-12-05 08:25:23 | AUPH | sell | $17.200 | short |
2019-12-05 08:29:06 | AUPH | buy | $17.020 | short |
2019-12-05 08:29:09 | AUPH | buy | $16.970 | short |
2019-12-05 08:29:09 | AUPH | buy | $16.920 | short |
2019-12-05 08:29:35 | AUPH | buy | $17.044 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!